IMARC Group, a leading market research company, has recently releases report titled “Pneumonia Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” Offers a comprehensive analysis of the industry, which comprises insights on the market.
How Big is the Pneumonia Testing Market?
The global pneumonia testing market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.4% during 2023-2028.
Industry Overview of Pneumonia Testing
Pneumonia is a respiratory infection caused by bacteria, viruses, or fungi, typically affecting the lower respiratory tract. It spreads through the inhalation of airborne droplets that are released when an infected person sneezes or coughs. It causes inflammation of the air sacs in the lungs, leading to shortness of breath, reduced appetite, and mild fever. Other symptoms of pneumonia include dry cough, headaches, fatigue, chills, and chest pain. At present, pneumonia can be diagnosed by pneumonia testing, including physical examination, medical history review, chest X-ray, blood culture, pulse oximetry, sputum culture, bronchoscopy, and fluid sample analysis across the globe.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/pneumonia-testing-market/requestsample
What are the growth prospects and trends in the pneumonia testing industry?
The global pneumonia testing market is primarily driven by the rising use of point of care (POC) testing to detect pneumonia on account of its higher efficiency and rapid and accurate test results. Moreover, the development of immunochromatographic, pneumococcal urinary antigen (UAT), and advanced nucleic acid detection tests is positively influencing the market growth.
Additionally, the rising number of pneumonia tests due to increasing awareness among individuals regarding the benefits of early diagnosis is propelling market growth. Furthermore, the surging adoption of the enzyme-linked immunosorbent assay (ELISA) to detect pneumonia, as it is highly sensitive and easier to conduct, is contributing to market growth.
Other factors, including expanding geriatric population, the rising focus of key players on launching new products, and rapid expansion in the healthcare industry, are also anticipated to drive the market further.
Leading Companies Operating in the Global Pneumonia Testing Industry:
- Abbott Laboratories
- Becton
- Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories Inc
- Curetis GmbH (OpGen)
- DiaSorin S.p.A.
- Hologic Inc
- Meridian Bioscience Inc
- Quest Diagnostics Incorporated
- Quidel Corporation
- Roche Holding AG
- Thermo Fisher Scientific Inc.
Pneumonia Testing Market Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- Analyzers
- Consumables
Breakup by Method:
- Immunodiagnostics
- Molecular Diagnostics
- Point of Care Testing
Breakup by Technology:
- Enzyme-linked Immunosorbent Assay
- Immunofluorescence
- Western Blot
- Polymerase Chain Reaction
- Immunohistochemistry
- Others
Breakup by End User:
- Hospitals
- Diagnostic Laboratories
- Homecare
- Others
Breakup by Region:
North America: (United States, Canada)
Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
